Japan Diabetes Market Expected to Reach USD 7.4 Billion by 2033 - IMARC Group

February 12, 2025 | Healthcare

VIEW FULL TABLE OF CONTENTS

Japan Diabetes Market Statistics, Outlook and Regional Analysis 2025-2033

The Japan diabetes market size was valued at USD 5.6 Billion in 2024, and it is expected to reach USD 7.4 Billion by 2033, exhibiting a growth rate (CAGR) of 3.2% from 2025 to 2033.

Japan Diabetes Market

To get more information on this market, Request Sample

The Japan diabetes market is witnessing significant advancements driven by an aging population, rising prevalence of type 2 diabetes, and evolving therapeutic innovations. The increasing demand for effective management options for diabetes, particularly among patients with comorbidities such as renal impairment, is a notable growth factor. Additionally, Japan’s robust healthcare infrastructure and focus on personalized medicine are fueling research and development efforts aimed at addressing diverse patient needs. Several key developments highlight this trend, emphasizing the focus on safety, efficacy, and simplified treatment regimens. For example, in August 2024, Sumitomo Pharma's TWYMEEG demonstrated safety in type 2 diabetes patients with renal impairment, paving the way for regulatory discussions to update its label for use in patients with an estimated glomerular filtration rate (eGFR) below 45 mL/min/1.72m². This breakthrough addresses a critical gap in the management of diabetes among patients with compromised kidney function.

Similarly, Eli Lilly's QWINT trials, reported in September 2024, established the safety and efficacy of once-weekly insulin efsitora alfa, offering an alternative to daily insulin for insulin-naïve and transitioning patients. The ability to maintain comparable A1C reduction with fewer administrations simplifies diabetes management and enhances patient adherence. These innovations reflect the industry’s shift towards convenient and patient-centered solutions. Moreover, the growing emphasis on novel drug classes and their mechanisms of action is also shaping the Japanese diabetes treatment landscape. In November 2024, a Japanese study highlighted the potential of imeglimin, a mitochondrial function-targeting agent, to enhance incretin secretion and β-cell function. Compared to metformin, imeglimin demonstrated superior efficacy in reducing HbA1c levels, thereby making it a promising option for addressing the diverse needs of diabetes patients, including those with complex conditions. These developments underscore the increasing focus on tailoring treatments to specific patient populations, improving safety profiles, and ensuring long-term effectiveness. As Japan continues to lead in diabetes research and innovation, the integration of advanced therapeutics into clinical practice will likely remain a key driver of market growth.

Top Companies Leading in the Japan Diabetes Industry

The diabetes market in Japan is expanding through strategic partnerships, innovative therapies, and patient education programs to meet the healthcare requirements of Japan. Also, this research report provides an extended analysis of the competitive landscape in the market with all the major companies. Furthermore, companies such as Novo Nordisk and Sanofi are inventing next-generation insulin therapy and glucose monitoring technologies. In addition, they run awareness initiatives to encourage diabetes management and work with regional suppliers for efficient product distribution. Consistent with these trends, Mitsubishi Tanabe Pharma Corporation introduced a new SGLT2 inhibitor for type 2 diabetes in May 2024 called CANAGLU OD Tablets. Moreover, MTPC allied with Eli Lilly Japan in April 2023 to develop an alternative treatment for type 2 diabetes.

Japan Diabetes Market Segmentation Coverage

On the basis of segment, the market has been categorized into oral antidiabetics and insulin, wherein insulin represents the most preferred segment. Insulin commands a sizeable portion of the market, driven by the rising incidence of diabetes among older populations and the growing preference for insulin therapies to regulate blood sugar effectively. Japan’s healthcare system, recognized for its robust diabetes care infrastructure, facilitates broad access to insulin treatments. Innovations in insulin delivery systems and formulations also contribute to improved patient outcomes. In congruence with these trends, Astellas Pharma Inc. announced a partnership with Roche Diabetes Care Japan in March 2023 to develop the Accu-Chek Guide Me monitoring system and BlueStar, an FDA-cleared digital diabetes solution by Welldoc.

Browse IMARC Related Reports on Diabetes Market:

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Japan Diabetes Market Expected to Reach USD 7.4 Billion by 2033 - IMARC Group

Purchase Options Discount
Offer

Inquire Before Buying

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.